Molecular, Clinical, and Therapeutic Determinants of Outcome in NPM1 Mutated AML

Researchers analyzed a large group of patients with NPM1mutated AML enrolled in prospective trials to delineate the impact of baseline molecular and clinical features, post induction measurable residual disease status and treatment intensity on outcome.